(2022) How To Code B20 ICD 10 – List With Codes & Guidelines
This article will outline the causes, symptoms, diagnosis, treatment and the ICD 10 CM code for B20.
B20 ICD 10 Causes
Most people diagnosed with B20 ICD 10 (HIV) in the UK develop the virus via unprotected vaginal or anal sex. It is possible to become infected with HIV through unprotected oral sex, but the risk is low. The risk is higher if a person has oral sex and has mouth ulcers, sores or bleeding in the gums, or if the person who has oral sex is infected with HIV and has much of the virus from a sexually transmitted infection in their body.
HIV is not air transmitted from one person to another. It does not spread through the air like a cold or flu virus. It lives in blood and bodily fluids.
Some bodily fluids contain enough HIV to infect: sperm and vaginal fluids, including menstrual blood, breast milk, and the anus’s bloodstream. Other bodily fluids such as saliva, sweat and urine do not contain HIV but can infect a person. The HIV-1 fluid is the HIV in the blood.
The main ways in which the virus enters the blood stream are injections into the bloodstream with a needle or an injection device and sharing the thin lining of the anus, the vagina and genitals or the thin lining of the mouth, eyes or cut or sore skin with other people. The virus cannot be transmitted by spitting, kissing, biting, contact with unbroken healthy skin, sneezing, sharing bathroom towels or cutlery, using the same toilet or swimming pool, mouth-to-mouth respiration or contact with animals or insects (e.g. Mosquitoes ).
Clinical latent infection (chronic HIV) is a stage of infection in which HIV is present in the body’s white blood cells. The amount of virus in the blood (viral load) is high over time. As a result, the infection can spread from the primary infection to the next level.
B20 ICD 10 Symptoms
The symptoms of B20 ICD 10 (HIV / AIDS) vary depending on the stage of infection. Usually, people infected with HIV develop a flu-like illness after the virus enters the body two to four weeks after infection. The disease usually lasts for a few weeks.
Possible signs and symptoms include:
- fever
- headache
- muscle pain
- joint pain
- rash
- sore throat
- mouth pain
- sore or swollen lymph glands in the neck
- diarrhea
- weight loss
- coughing
- night sweats.
- These symptoms can be mild, and some patients don’t even notice them.
B20 ICD 10 Diagnosis
There are various tests available to diagnose B20 ICD 10 (HIV). Healthcare providers determine which test is best for each person. Antibody and antigen tests are the most commonly used tests. These tests usually show a positive result within 18 to 45 days of being infected with HIV.
These are tests that detect blood antibodies. Antibodies are proteins that the body makes to respond to infections. Antigens, on the other hand, are parts of the virus that activate the immune system. Within 23 to 90 days of transmission, most people develop detectable HIV antibodies found in blood and saliva. These tests test both blood antibodies and antigens.
These tests can be done either with a blood test or a mouth swab, and no preparation is required. These tests can yield results within 30 minutes or less and can be performed at a healthcare provider’s office or clinic. In order to access an HIV-1 test system at home, a person simply sticks his finger and sends a blood sample to a licensed laboratory. Other antibodies tests can also be done at home, such as the OraQuick HIV test with an oral swab that delivers results in just 20 minutes.
If you remain anonymous, call the results the next business day. If someone is suspected of being exposed to HIV, test negative at home and repeat the test in 3 months. If a positive outcome is pursued with your healthcare provider, you confirm this.
Nucleic acid tests (NATs) are designed for people who show early symptoms of HIV or know risk factors. These tests do not look for antibodies, but for HIV.
It takes 5 to 21 days for HIV to be detected in the blood. Today it is easier than ever to test for HIV. These tests are often accompanied by a confirmed antibody test.
In 2016 the WHO recommended lifelong ART for all people with HIV, including children, adolescents, adults, pregnant women and nursing women, regardless of their clinical status or CD4+ cell count. In June 2020, 82% of low- and middle-income countries reported having implemented this policy, but only half of these countries reported a nationwide implementation. In June 2021, 187 countries adopted the WHO recommendation, which covers 99% of all people infected with HIV. In addition, the WHO Treatment Strategy recommends rapid GRT initiation for all HIV patients, including the provision of GRT on the same day of diagnosis and before treatment begins.
This corresponds to a global GRT coverage rate of 73% (56 out of 88). Some 27.5 million (26.5 out of 27.7 million) people living with HIV will receive GRT in 2020.
However, greater efforts are needed to extend the treatment of children and adolescents. Only 54% (37 / 69) of children aged 0-14 will receive GRT by the end of 2020.
B20 ICD 10 Treatment
B20 ICD 10 (HIV) treatment can reduce the risk of HIV being transmitted to someone else with the infection. HIV-infected people can transmit the infection to others in the weeks after infection. An HIV-infected person can transmit the virus to others, even if they have no symptoms.
Thanks to better antiviral treatments, most people with HIV in the US today do not contract AIDS. However, AIDS can still occur if the immune system is compromised. If left untreated, HIV can become AIDS within 8 to 10 years.
HIV can be treated with a regimen consisting of a combination of three antiretroviral drugs (ARV). Current antiretroviral therapy (ART) does not cure HIV infection, but suppresses viral replication in the body, strengthening the immune system and restoring the ability to fight opportunistic infections and cancer.
ICD 10 Code For B20
ICD 10 CM B20 Human immunodeficiency virus disease (HIV)
Related ICD 10 CM Codes:
ICD 10 CM B20.0 HIV disease resulting in mycobacterial infection
ICD 10 CM B20.1 HIV disease resulting in other bacterial infections
ICD 10 CM B20.2 HIV disease resulting in cytomegaloviral disease
ICD 10 CM B20.3 HIV disease resulting in other viral infections
ICD 10 CM B20.4 HIV disease resulting in candidiasis
ICD 10 CM B20.5 HIV disease resulting in other mycoses
ICD 10 CM B20.6 HIV disease resulting in Pneumocystis carinii pneumonia
ICD 10 CM B20.7 HIV disease resulting in multiple infections
ICD 10 CM B20.8 HIV disease resulting in other infectious and parasitic diseases
ICD 10 CM B20.9 HIV disease resulting in unspecified infectious or parasitic disease
ICD 10 CM B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
ICD 10 CM B21.0 HIV disease resulting in Kaposi’s sarcoma
ICD 10 CM B21.1 HIV disease resulting in Burkitt’s lymphoma
ICD 10 CM B21.2 HIV disease resulting in other types of non-Hodgkin’s lymphoma
ICD 10 CM B21.3 HIV disease resulting in other malignant neoplasms of lymphoid haematopoietic and related tissue
ICD 10 CM B21.7 HIV disease resulting in multiple malignant neoplasms
ICD 10 CM B21.8 HIV disease resulting in other malignant neoplasms
ICD 10 CM B21.9 HIV disease resulting in unspecified malignant neoplasm
ICD 10 CM B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases
ICD 10 CM B22.0 HIV disease resulting in encephalopathy
ICD 10 CM B22.1 HIV disease resulting in lymphoid interstitial pneumonitis
ICD 10 CM B22.2 HIV disease resulting in wasting syndrome
ICD 10 CM B22.7 HIV disease resulting in multiple diseases classified elsewhere
ICD 10 CM B23 Human immunodeficiency virus [HIV] disease resulting in other conditions
ICD 10 CM B23.0 Acute HIV infection syndrome
ICD 10 CM B23.1 HIV disease resulting in (persistent) generalized lymphadenopathy
ICD 10 CM B23.2 HIV disease resulting in haematological and immunological abnormalities not elsewhere classified
ICD 10 CM B23.8 HIV disease resulting in other specified conditions
ICD 10 CM B24 Unspecified human immunodeficiency virus [HIV] disease
